---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-016338"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2025-04-29T23:59:59+00:00"
generated_at: "2026-05-23T03:30:36.997921+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Director R. Keith Woods not standing for re-election to Rocket board

## Summary
- R. Keith Woods informed board he accepted COO role at another biopharma company; will not stand for re-election at 2025 annual meeting.
- His term as director and membership on audit and commercial committees ends at the 2025 annual meeting.
- Departure is not due to any disagreement with Rocket's operations, policies, or practices.

## SEC filing metadata
- accession: 0001140361-25-016338
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2025-04-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036125016338/0001140361-25-016338-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125016338/ef20048161_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-016338
- JSON: https://secwatch.observer/filing/0001140361-25-016338.json
- Plain text: https://secwatch.observer/filing/0001140361-25-016338.txt

## Key facts
- Executive change
  R. Keith Woods departed as Director at ROCKET PHARMACEUTICALS, INC..
  - Action: decided not to stand for re-election
  - Role: Director
  source text: On April 26, 2025, R. Keith Woods informed the board of directors (the “Board”) of Rocket Pharmaceuticals, Inc. (the “Company”) that he has accepted a Chief Operating Officer position with a biopharmaceutical company and therefore has decided not to stand for re-election to the Board at the Company’s upcoming 2025 annual meeting (the “2025 Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1281895/000114036125016338/0001140361-25-016338-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.